Search for: "Bush v. Williams et al" Results 41 - 55 of 55
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2021, 5:01 am by Jordan Brunner
The administration didn’t publish the list even after then-Secretary of Defense William Cohen assured then-Rep. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
26 Jun 2014, 9:01 pm by John Dean
Overview of the No-Fly List The ACLU’s lawsuit, Latif et al v. [read post]
9 Aug 2012, 5:00 am by Bexis
Clarus Medical (laser) Deposition2005-07-11 Williams v. [read post]
17 Feb 2023, 1:29 pm by admin
One of the most remarkable, and objectionable, aspects of the third edition was its failure to engage with Federal Rule of Evidence of 703, and the need for courts to assess the validity of individual studies relied upon. [read post]
15 Aug 2013, 8:10 am
(Pix (c) Larry Catá Backer 2013)In 2010, the faculty at Penn State Law approved the creation of a new concept course, to be named "Elements of Law". [read post]
7 Jun 2023, 8:30 am by Guest Author
Bush Administration issuing prompt letters and Circular A-4; and the Obama administration emphasizing dignity and retrospective review. [read post]
President Trump recently announced that he is nominating William Barr—who served in the first Bush administration—to replace Sessions. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]